The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Genetic mutations and mechanisms in dilated cardiomyopathy
Open accessAbstract
Genetic mutations account for a significant percentage of cardiomyopathies, which are a leading cause of congestive heart failure.In hypertrophic cardiomyopathy (HCM), cardiac output is limited by the thickened myocardium through impaired filling and outflow.Mutations in the genes encoding the thick filament components myosin heavy chain and myosin binding protein C (MYH7 and MYBPC3) together explain 75% of inherited HCMs, leading to the observation that HCM is a disease of the sarcomere.Many mutations are "private" or rare variants, often unique to families.In contrast, dilated cardiomyopathy (DCM) is far more genetically heterogeneous, with mutations in genes encoding cytoskeletal, nucleoskeletal, mitochondrial, and calcium-handling proteins.DCM is characterized by enlarged ventricular dimensions and impaired systolic and diastolic function.Private mutations account for most DCMs, with few hotspots or recurring mutations.More than 50 single genes are linked to inherited DCM, including many genes that also link to HCM.Relatively few clinical clues guide the diagnosis of inherited DCM, but emerging evidence supports the use of genetic testing to identify those patients at risk for faster disease progression, congestive heart failure, and arrhythmia. Cardiomyopathy: diagnosis and prevalenceCardiomyopathy is defined by a pathologically abnormal myocardium.There are four major classifications of cardiomyopathy: dilated (DCM), hypertrophic (HCM), restrictive (RCM), and arrhythmogenic RV (ARVC).Cardiomyopathy is most commonly diagnosed through in vivo imaging, with either echocardiography or, increasingly, cardiac MRI.DCM refers to enlargement of the heart, which often affects all four chambers, especially late in the disease.Most commonly, DCM is associated with reduced LV function or systolic function, although early in the disease the LV may be dilated, with only minimally reduced function.In contrast, HCM is characterized by increased LV wall thickness, often targeting the septum that separates the LV from the RV (Figure 1).RCM is the most elusive, in part because the heart may appear morphologically close to normal, with only minor increased wall thickness or modestly decreased LV ejection fraction.The infiltrative process underlying RCM is often not readily detectable in vivo with even the most sensitive imaging technique.RCM is characterized by impaired filling of the heart, known as diastolic dysfunction, which reduces cardiac output.ARVC is characterized by reduced function and thinning of the RV with a fibrofatty infiltration that can be seen on MRI.Myocardial ischemia remains a common cause of DCM, accounting for approximately half of DCM.Toxic, metabolic, and immunologic causes have each been linked to DCM, as well as hypertension and valvular disease.Genetic cardiomyopathy, which runs in families, is now more commonly diagnosed, largely because surveillance for and awareness of the condition have improved.It is also now increasingly understood that more than one etiology may contribute to DCM within a given individual.Unlike cardiomyopathy that results from some of the other causes, genetic cardiomyopathy is a progressive disease.The time course is highly dependent on the age of presentation, which relates to
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hypertrophic Cardiomyopathy: A Systematic Review
Maron, B. J. (2002) · JAMA · doi:10.1001/jama.287.10.1308 · Cited by 2,224
Truncations of titin causing dilated cardiomyopathy
Herman, D. S., Lam, L., Taylor, M. R. G., Wang, L., Teekakirikul, P., Christodoulou, D., Conner, L., DePalma, S. R., McDonough, B., Sparks, E., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1110186 · Cited by 1,485
Lamin A/C deficiency causes defective nuclear mechanics and mechanotransduction
Lammerding, J., Schulze, P. C., Takahashi, T., Kozlov, S. V., Sullivan, T. L., Kamm, R. D., Stewart, C. L., & Lee, R. T. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19670 · Cited by 1,064
Transforming growth factor (TGF)-β signaling in cardiac remodeling
Dobaczewski, M., Chen, W., & Frangogiannis, N. G. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.10.033 · Cited by 934
Knöll, R., Hoshijima, M., Hoffman, H. M., Person, V., Lorenzen-Schmidt, I., Bang, M.-L., Hayashi, T., Shiga, N., Yasukawa, H., Schaper, W., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)01226-6 · Cited by 786
Mutations in Sarcomere Protein Genes as a Cause of Dilated Cardiomyopathy
Kamisago, M., Sharma, S. D., DePalma, S. R., Solomon, S., Sharma, P., McDonough, B., Smoot, L., Mullen, M. P., Woolf, P. K., Wigle, E. D., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012073432304 · Cited by 720
Myocardial Fibrosis as an Early Manifestation of Hypertrophic Cardiomyopathy
Ho, C. Y., López, B., Coelho-Filho, O. R., Lakdawala, N. K., Cirino, A. L., Jarolim, P., Kwong, R., González, A., Colan, S. D., Seidman, J. G., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002659 · Cited by 696
Codd, M. B., Sugrue, D. D., Gersh, B. J., & Melton, L. J. (1989) · Circulation · doi:10.1161/01.cir.80.3.564 · Cited by 640
Mutations of TTN, encoding the giant muscle filament titin, cause familial dilated cardiomyopathy
Gerull, B., Gramlich, M., Atherton, J., McNabb, M., Trombitás, K., Sasse-Klaassen, S., Seidman, J. G., Seidman, C., Granzier, H., Labeit, S., et al. (2002) · Nature Genetics · doi:10.1038/ng815 · Cited by 616
Zhang, Q., Bethmann, C., Worth, N. F., Davies, J. D., Wasner, C., Feuer, A., Ragnauth, C. D., Yi, Q., Mellad, J. A., Warren, D. T., et al. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm238 · Cited by 539
Risk Factors for Malignant Ventricular Arrhythmias in Lamin A/C Mutation Carriers
van Rijsingen, I. A. W., Arbustini, E., Elliott, P. M., Mogensen, J., Hermans-van Ast, J. F., van der Kooi, A. J., van Tintelen, J. P., van den Berg, M. P., Pilotto, A., Pasotti, M., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.08.078 · Cited by 537
Small, K. M., Wagoner, L. E., Levin, A. M., Kardia, S. L. R., & Liggett, S. B. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020803 · Cited by 530
The Dystrophin Glycoprotein Complex: Signaling Strength and Integrity for the Sarcolemma
Lapidos, K. A., Kakkar, R., & McNally, E. M. (2004) · Circulation Research · doi:10.1161/01.res.0000126574.61061.25 · Cited by 524
Self-citationNagueh, S. F., Shah, G., Wu, Y., Torre-Amione, G., King, N. M. P., Lahmers, S., Witt, C. C., Becker, K., Labeit, S., & Granzier, H. L. (2004) · Circulation · doi:10.1161/01.cir.0000135591.37759.af · Cited by 486
Duboc, D., Meune, C., Lerebours, G., Devaux, J., Vaksmann, G., & Bécane, H. M. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.09.078 · Cited by 462
Mutations in Sarcomere Protein Genes in Left Ventricular Noncompaction
Klaassen, S., Probst, S., Oechslin, E., Gerull, B., Krings, G., Schuler, P., Greutmann, M., Hürlimann, D., Yegitbasi, M., Pons, L., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.746164 · Cited by 451
Ingles, J., Doolan, A., Chiu, C., Seidman, J., Seidman, C., & Semsarian, C. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2005.033886 · Cited by 385
Abnormal nuclear shape and impaired mechanotransduction in emerin-deficient cells
Lammerding, J., Hsiao, J., Schulze, P. C., Kozlov, S., Stewart, C. L., & Lee, R. T. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200502148 · Cited by 381
Arbustini, E., Pilotto, A., Repetto, A., Grasso, M., Negri, A., Diegoli, M., Campana, C., Scelsi, L., Baldini, E., Gavazzi, A., et al. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01724-2 · Cited by 358
Villard, E., Perret, C., Gary, F., Proust, C., Dilanian, G., Hengstenberg, C., Ruppert, V., Arbustini, E., Wichter, T., Germain, M., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr105 · Cited by 347
Perindopril preventive treatment on mortality in Duchenne muscular dystrophy: 10 years' follow-up
Duboc, D., Meune, C., Pierre, B., Wahbi, K., Eymard, B., Toutain, A., Berard, C., Vaksmann, G., Weber, S., & Bécane, H.-M. (2007) · American Heart Journal · doi:10.1016/j.ahj.2007.05.014 · Cited by 343
Liggett, S. B., Wagoner, L. E., Craft, L. L., Hornung, R. W., Hoit, B. D., McIntosh, T. C., & Walsh, R. A. (1998) · Journal of Clinical Investigation · doi:10.1172/jci4059 · Cited by 341
Perez, J. M., Rathz, D. A., Petrashevskaya, N. N., Hahn, H. S., Wagoner, L. E., Schwartz, A., Dorn, G. W., & Liggett, S. B. (2003) · Nature Medicine · doi:10.1038/nm930 · Cited by 333
Dystrophic heart failure blocked by membrane sealant poloxamer
Yasuda, S., Townsend, D., Michele, D. E., Favre, E. G., Day, S. M., & Metzger, J. M. (2005) · Nature · doi:10.1038/nature03844 · Cited by 313
Tcap gene mutations in hypertrophic cardiomyopathy and dilated cardiomyopathy
Hayashi, T., Arimura, T., Itoh-Satoh, M., Ueda, K., Hohda, S., Inagaki, N., Takahashi, M., Hori, H., Yasunami, M., Nishi, H., et al. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.08.058 · Cited by 302
Genetic Variation in Titin in Arrhythmogenic Right Ventricular Cardiomyopathy–Overlap Syndromes
Taylor, M., Graw, S., Sinagra, G., Barnes, C., Slavov, D., Brun, F., Pinamonti, B., Salcedo, E. E., Sauer, W., Pyxaras, S., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.005405 · Cited by 295
Girolami, F., Ho, C. Y., Semsarian, C., Baldi, M., Will, M. L., Baldini, K., Torricelli, F., Yeates, L., Cecchi, F., Ackerman, M. J., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.11.062 · Cited by 294
The National Institutes of Health Undiagnosed Diseases Program: insights into rare diseases
Gahl, W. A., Markello, T. C., Toro, C., Fajardo, K. F., Sincan, M., Gill, F., Carlson-Donohoe, H., Gropman, A., Pierson, T. M., Golas, G., et al. (2012) · Genetics in Medicine · doi:10.1038/gim.0b013e318232a005 · Cited by 291
Mohapatra, B., Jimenez, S., Lin, J. H., Bowles, K. R., Coveler, K. J., Marx, J. G., Chrisco, M. A., Murphy, R. T., Lurie, P. R., Schwartz, R. J., et al. (2003) · Molecular Genetics and Metabolism · doi:10.1016/s1096-7192(03)00142-2 · Cited by 269
Cardiomyopathy in zebrafish due to mutation in an alternatively spliced exon of titin
Xu, X., Meiler, S. E., Zhong, T. P., Mohideen, M., Crossley, D. A., Burggren, W. W., & Fishman, M. C. (2002) · Nature Genetics · doi:10.1038/ng816 · Cited by 264
The Pediatric Cardiomyopathy Registry and Heart Failure: Key Results from the First 15 Years
Wilkinson, J. D., Landy, D. C., Colan, S. D., Towbin, J. A., Sleeper, L. A., Orav, E. J., Cox, G. F., Canter, C. E., Hsu, D. T., Webber, S. A., et al. (2010) · Heart Failure Clinics · doi:10.1016/j.hfc.2010.05.002 · Cited by 219
Latent TGF-β–binding protein 4 modifies muscular dystrophy in mice
Heydemann, A., Ceco, E., Lim, J. E., Hadhazy, M., Ryder, P., Moran, J. L., Beier, D. R., Palmer, A. A., & McNally, E. M. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39845 · Cited by 218
Self-citationNexilin mutations destabilize cardiac Z-disks and lead to dilated cardiomyopathy
Hassel, D., Dahme, T., Erdmann, J., Meder, B., Huge, A., Stoll, M., Just, S., Hess, A., Ehlermann, P., Weichenhan, D., et al. (2009) · Nature Medicine · doi:10.1038/nm.2037 · Cited by 211
Knock-In Mouse Model of Dilated Cardiomyopathy Caused by Troponin Mutation
Du, C.-K., Morimoto, S., Nishii, K., Minakami, R., Ohta, M., Tadano, N., Lu, Q.-W., Wang, Y.-Y., Zhan, D.-Y., Mochizuki, M., et al. (2007) · Circulation Research · doi:10.1161/circresaha.106.146670 · Cited by 177
Wagoner, L. E., Craft, L. L., Singh, B., Suresh, D. P., Zengel, P. W., McGuire, N., Abraham, W. T., Chenier, T. C., Dorn, G. W., & Liggett, S. B. (2000) · Circulation Research · doi:10.1161/01.res.86.8.834 · Cited by 173
Thin Filament Mutations: Developing an Integrative Approach to a Complex Disorder
Tardiff, J. C. (2011) · Circulation Research · doi:10.1161/circresaha.110.224170 · Cited by 170
Primary laminopathy fibroblasts display altered genome organization and apoptosis
Meaburn, K. J., Cabuy, E., Bonne, G., Lévy, N., Morris, G. E., Novelli, G., Kill, I. R., & Bridger, J. M. (2007) · Aging Cell · doi:10.1111/j.1474-9726.2007.00270.x · Cited by 164
Nesprins LINC the nucleus and cytoskeleton
Mellad, J. A., Warren, D. T., & Shanahan, C. M. (2011) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2010.11.006 · Cited by 160
ANKRD1, the Gene Encoding Cardiac Ankyrin Repeat Protein, Is a Novel Dilated Cardiomyopathy Gene
Moulik, M., Vatta, M., Witt, S. H., Arola, A. M., Murphy, R. T., McKenna, W. J., Boriek, A. M., Oka, K., Labeit, S., Bowles, N. E., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.02.076 · Cited by 153
Common Variants in HSPB7 and FRMD4B Associated With Advanced Heart Failure
Cappola, T. P., Li, M., He, J., Ky, B., Gilmore, J. M., Qu, L., Keating, B. J., Reilly, M. P., Kim, C. E., Glessner, J., et al. (2010) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.109.898395 · Cited by 149
Nesprin-1 mutations in human and murine cardiomyopathy
Puckelwartz, M. J., Kessler, E. J., Kim, G. H., DeWitt, M. M., Zhang, Y., Earley, J. U., Depreux, F. F. S., Holaska, J. M., Mewborn, S. K., Pytel, P., et al. (2009) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2009.11.006 · Cited by 147
Self-citationFamilial Dilated Cardiomyopathy Caused by an Alpha-Tropomyosin Mutation
Lakdawala, N. K., Dellefave‐Castillo, L. M., Redwood, C. S., Sparks, E. A., Cirino, A. L., DePalma, S. R., Colan, S. D., Funke, B., Zimmerman, R., Robinson, P. J., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.11.017 · Cited by 137
Self-citationCardiac titin: Structure, functions and role in disease
LeWinter, M. M., Wu, Y., Labeit, S., & Granzier, H. L. M. (2006) · Clinica Chimica Acta · doi:10.1016/j.cca.2006.06.035 · Cited by 136
Altered Chromosomal Positioning, Compaction, and Gene Expression with a Lamin A/C Gene Mutation
Mewborn, S. K., Puckelwartz, M. J., Abuisneineh, F., Fahrenbach, J. P., Zhang, Y., MacLeod, H. M., Dellefave‐Castillo, L. M., Pytel, P., Selig, S., Labno, C. M., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014342 · Cited by 136
Self-citationCytoskeletal protein kinases: titin and its relations in mechanosensing
Gautel, M. (2011) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-011-0946-1 · Cited by 134
Review and Metaanalysis of the Frequency of Familial Dilated Cardiomyopathy
Petretta, M., Pirozzi, F., Sasso, L., Paglia, A., & Bonaduce, D. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.06.022 · Cited by 126
Lamin A/C–mediated neuromuscular junction defects in Emery-Dreifuss muscular dystrophy
Méjat, A., Decostre, V., Li, J., Renou, L., Kesari, A., Hantaï, D., Stewart, C. L., Xiao, X., Hoffman, E. P., Bonne, G., et al. (2009) · The Journal of Cell Biology · doi:10.1083/jcb.200811035 · Cited by 125
Evaluating Pathogenicity of Rare Variants From Dilated Cardiomyopathy in the Exome Era
Norton, N., Robertson, P. D., Rieder, M. J., Zuchner, S. L., Rampersaud, E., Martin, E. R., Li, D., Nickerson, D. A., & Hershberger, R. E. (2012) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.111.961805 · Cited by 125
Epidemiology of idiopathic cardiomyopathy in Japan: results from a nationwide survey
Miura, K., Nakagawa, H., Morikawa, Y., Sasayama, S., Matsumori, A., Hasegawa, K., Ohno, Y., Tamakoshi, A., Kawamura, T., & Inaba, Y. (2002) · Heart · doi:10.1136/heart.87.2.126 · Cited by 122
Cappola, T. P., Matkovich, S. J., Wang, W., Booven, D. V., Li, M., Wang, X., Qu, L., Sweitzer, N. K., Fang, J. C.-T., Reilly, M. P., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1017494108 · Cited by 114
The sensitive giant: the role of titin-based stretch sensing complexes in the heart
Miller, M. (2004) · Trends in Cell Biology · doi:10.1016/j.tcb.2004.01.003 · Cited by 111
Purevjav, E., Arimura, T., Augustin, S., Huby, A.-C., Takagi, K., Nunoda, S., Kearney, D. L., Taylor, M. D., Terasaki, F., Bos, J. M., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds022 · Cited by 109
Schmitt, J. P., Debold, E. P., Ahmad, F., Armstrong, A., Frederico, A., Conner, D. A., Mende, U., Lohse, M. J., Warshaw, D. M., Seidman, C. E., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606383103 · Cited by 105
Sarcomere Mutations in Cardiomyopathy With Left Ventricular Hypertrabeculation
Dellefave‐Castillo, L. M., Pytel, P., Mewborn, S. K., Mora, B. N., Guris, D. L., Fedson, S., Waggoner, D., Moskowitz, I. P. G., & McNally, E. M. (2009) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.109.861955 · Cited by 95
Self-citationTnni3k Modifies Disease Progression in Murine Models of Cardiomyopathy
Wheeler, F. C., Tang, H., Marks, O. A., Hadnott, T. N., Chu, P., Mao, L., Rockman, H. A., & Marchuk, D. A. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000647 · Cited by 83
Mutations in the ANKRD1 gene encoding CARP are responsible for human dilated cardiomyopathy
Duboscq-Bidot, L., Charron, P., Ruppert, V., Fauchier, L., Richter, A., Tavazzi, L., Arbustini, E., Wichter, T., Maisch, B., Michel Komajda, N., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp225 · Cited by 75
Lamin A/C deficiency as a cause of familial dilated cardiomyopathy
Malhotra, R., & Mason, P. K. (2009) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e32832a11c6 · Cited by 56
Dyer, E., Jacques, A. M., Hoskins, A. C., Ward, D. G., Gallon, C. E., Messer, A. E., Kaski, J. P., Burch, M., Kentish, J. C., & Marston, S. B. (2009) · Circulation Heart Failure · doi:10.1161/circheartfailure.108.818237 · Cited by 51
Multiple quantitative trait loci modify the heart failure phenotype in murine cardiomyopathy
Corvoisier, P. L. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg333 · Cited by 34
Distinct genetic regions modify specific muscle groups in muscular dystrophy
Swaggart, K. A., Heydemann, A., Palmer, A. A., & McNally, E. M. (2010) · Physiological Genomics · doi:10.1152/physiolgenomics.00172.2010 · Cited by 29
Self-citationCardiac troponin T mutations promote life-threatening arrhythmias
Fiset, C., & Giles, W. R. (2008) · Journal of Clinical Investigation · doi:10.1172/jci37787 · Cited by 27
Cited by
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab670 · Cited by 19,442
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw128 · Cited by 11,429
2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.592 · Cited by 5,866
Dilated Cardiomyopathy: Genetic Determinants and Mechanisms
McNally, E. M., & Mestroni, L. (2017) · Circulation Research · doi:10.1161/circresaha.116.309396 · Cited by 786
Self-citationPathological Ventricular Remodeling: Mechanisms: Part 1 of 2
Burchfield, J. S., Xie, M., & Hill, J. A. (2013) · Circulation · doi:10.1161/circulationaha.113.001878 · Cited by 766
Metadata
- Authors
- McNally, E. M., Golbus, J. R., & Puckelwartz, M. J.
- Venue
- Journal of Clinical Investigation
- Published
- 2013-01-02
- Volume
- 123
- Issue
- 1
- Pages
- 19-26
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2011112539
- Cited by
- 478
- References
- 61
- FWCI
- 30.93
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.